These added health benefits make it an attractive option for individuals with obesity-related health issues
They can help you understand the potential risks and benefits of Ozempic treatment in your individual case and to develop a treatment plan that is right for you
This improved comfort may be related to: More balanced hormonal signaling (GLP-1 + GIP) GIP activity that may reduce GLP-1-related nausea Smoother appetite regulation at equivalent weight-loss levels Personalized dosing and slow titration are essential for both medications
Like any medication, there is a potential for side effects when taking semaglutide, oral semaglutide, or tirzepatide
Although numerically lower rates were observed in the class I and class IIIII obesity subgroups, small event counts, particularly in the overweight group, limit interpretability
For pregnancy planning, discontinuation timing is product-specific: Semaglutide (Ozempic, Wegovy): Stop at least 2 months before attempting conception For other GLP-1 medications: Consult the specific product information and discuss with your healthcare provider Healthcare professionals should counsel patients of reproductive age about these considerations and the importance of effective contraception whilst on treatment